Success Stories: NIW Petition Approved for Research Fellow in Massachusetts in the Field of Molecular Medicine
Client’s Testimonial:
Thanks very much for all the help in the whole process! We are really grateful for that.
On August 21st, 2015 We Received EB-2 NIW (National Interest Waiver) Approval (Approval Notice) for a Research Fellow in the Field of Molecular Medicine
Position at the Time of Case Filing: Research Fellow
Country of Origin: China
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: August 21st, 2015
Processing Time: 4 months, 5 days
The client that North America Immigration Law Group – WeGreened.com had the opportunity to work with in this case was a Research Fellow from China. His work had focused specifically on the field of Molecular Medicine. We successfully demonstrated that his continued employment in the field would benefit those in his field, as well as the citizens of the United States at large. In order for our client’s case to be successful, we submitted extensive documentation proving his highly significant contributions to his field, including 4 peer-reviewed journal articles and at least one conference presentation. His publications had been cited at least 96 times at the time we filed the case; nearly all of the citations were by independent researchers around the world, demonstrating that these publications are widely recognized and relied upon in the field. The importance of his work was confirmed in the following quote from an independent recommender, “[Client] is at the top of [his] field and although I have not collaborated with [him] in any aspect to date, I have encountered and utilized [his] plentiful research extensively given its exceptional nature.” Through extensive documentation, we were able to successfully argue that our client would serve the national interest to a significantly greater degree than others with similar education and experience. His NIW petition was approved in 4 months and 5 days.

